Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Institutes of Health (NIH)
Pharma
NIH stops Xarelto arm of stroke trial due to safety, efficacy
An independent data monitoring board identified “an increase in safety events and evidence of futility” for the Xarelto arm, the NIH said.
Angus Liu
Feb 10, 2026 4:04pm
FDA signs off on expansion for Gamida Cell's Omisirge
Dec 9, 2025 8:19am
FDA urges doctors to minimize Tylenol use during pregnancy
Sep 23, 2025 8:55am
HHS, NIH, CDC leaders to steer revived vaccine safety panel
Aug 14, 2025 3:52pm
Fierce Biotech
At cell and gene roundtable, officials pledge to slash regulations
Jun 5, 2025 2:50pm
Eyeing tariffs, BMS unveils 5-year, $40B US investment
May 6, 2025 10:30am
